BeOne Medicines Ltd.
ONC
$308.63
-$5.04-1.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.52% | 46.61% | 23.43% | 12.11% | 70.75% |
| Total Depreciation and Amortization | 100.05% | 98.25% | 100.87% | 401.39% | 23.79% |
| Total Amortization of Deferred Charges | 109.96% | 15.95% | 28.17% | 392.53% | 38.13% |
| Total Other Non-Cash Items | 1,312.15% | 2,006.19% | 4,669.03% | 573.13% | -88.85% |
| Change in Net Operating Assets | 110.90% | 62.84% | 55.83% | -16,833.02% | 26.38% |
| Cash from Operations | 181.88% | 122.61% | 86.46% | 37.50% | 60.78% |
| Capital Expenditure | 40.45% | 30.26% | 8.16% | 0.69% | -19.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -787.61% | -137.16% | -109.12% | -111.12% | -101.01% |
| Cash from Investing | 26.18% | -17.75% | -1,236.02% | -252.93% | -212.28% |
| Total Debt Issued | -1.11% | 4.35% | 37.79% | 168.08% | 82.12% |
| Total Debt Repaid | 11.73% | -9.48% | 14.79% | 62.86% | -181.33% |
| Issuance of Common Stock | 71.71% | 55.58% | 10.74% | 2.86% | 140.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.81% | 6.81% | 6.81% | 6.81% | -- |
| Other Financing Activities | -50.04% | -21.67% | -21.67% | -7.47% | -- |
| Cash from Financing | -96.40% | -99.28% | -51.67% | 817.60% | 190.70% |
| Foreign Exchange rate Adjustments | -79.68% | 36.53% | -567.69% | -123.38% | 129.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.78% | 59.24% | 16.58% | -22.01% | 28.76% |